✦ LIBER ✦

Efficacy and biomarker findings from AVaglio, a phase III trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma

✍ Scribed by Wick, W.; Cloughesy, T.; Mason, W.; Henriksson, R.; Saran, F.; Nishikawa, R.; Hilton, M.; Garcia, J.; Pallaud, C.; Chinot, O.

Book ID: 122912028
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 63 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.2268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AVAglio: Phase 3 trial of bevacizumab pl

AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme

✍ O. L. Chinot; T. de La Motte Rouge; N. Moore; A. Zeaiter; A. Das; H. Phillips; Z 📂 Article 📅 2011 🏛 Springer Healthcare Communications 🌐 English ⚖ 625 KB

Concomitant and adjuvant temozolomide (T

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC

✍ Stupp, R.; Mason, W.P.; Van Den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M. 📂 Article 📅 2005 🏛 Masson Editeur 🌐 French ⚖ 45 KB

Preliminary Results from a Multicenter,

Preliminary Results from a Multicenter, Phase II, Randomized, Non-comparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma

✍ B.M. Alexander; E.C. Quant; T.B. Batchelor; D.S. Schiff; T.J. Kaley; J. Drappatz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB